K-numberK243689
Device nameAVIEW
ApplicantCoreline Soft Co., Ltd.
Product codeQIH
Device classClass II
Decision dateMar 19, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

AVIEW is a software system that analyzes CT thoracic and cardiac images to provide quantitative measurements of lung nodules, airways, and coronary arteries. It segments pulmonary structures, characterizes nodules with measurements like volume and density, calculates calcium scores for coronary risk assessment, and integrates with CAD software. The system stores and displays imaging data on-premises or in cloud environments accessible via mobile devices and browsers, intended for adult patients only.

Technological characteristics

AVIEW version 2.0 maintains the same technological characteristics as the predicate device in terms of materials, energy source, and control mechanisms. Software features have been modified with UI changes to various analysis pages (LAA, airway wall, fissure completeness, LCS, CAC), a new summary page, updated installation icons, and an added function to calculate arterial age based on Agatston score. The core intended use, indications, and algorithms remain unchanged from the predicate device.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

The device is substantially equivalent because it maintains the same intended use and principle of operation as the predicate AVIEW (K214036), with no changes to core functionality or algorithms. The modifications are primarily user interface enhancements and operational environment changes that do not introduce new safety risks or raise questions of safety or effectiveness. Non-clinical testing supported by software validation and verification demonstrates the device performs equivalently, and no new scientific technology is introduced. Clinical testing was not required because the indications for use are identical to the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →